Fibrate (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fibrate" in French language version.

refsWebsite

Global rank French rank

2,374^th place

298^th place

4^th place

12^th place

2,393^rd place

506^th place

1ahajournals.org

3,608^th place

659^th place

ahajournals.org

circ.ahajournals.org

The Bezafibrate Infarction Prevention Study Group, Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease, Circulation, 2000;102:21-27

nejm.org

Frick MH, Elo O, Haapa K et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia, N Engl J Med, 1987;317:1237-1245
Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol, N Engl J Med, 1999;341:410-418
Ginsberg HN, Elam MB, Lovato LC et al. Effects of combination lipid therapy in type 2 diabetes mellitus, N Engl J Med, 2010;362:1563-1574

nih.gov

ncbi.nlm.nih.gov

Birjmohun RS, Hutten BA, Kastelein JJ et als. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials, J Am Coll Cardiol, 2005;45:185-197
Davidson MH, Armani A, McKenney JM, Jacobson TA, Safety considerations with fibrate therapy, Am J Cardiol, 2007;99:3C-18C

thelancet.com

Jun M, Foote C, Lv J et als. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis, Lancet, 2010;375:1875-1884
Keech A, Simes RJ, Barter P et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial, Lancet, 2005;366:1849-1861